tiprankstipranks
Trending News
More News >
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market

Immuno-Biological Laboratories Co., Ltd. (4570) Price & Analysis

Compare
0 Followers

4570 Stock Chart & Stats


Financials

4570 FAQ

What was Immuno-Biological Laboratories Co., Ltd.’s price range in the past 12 months?
Immuno-Biological Laboratories Co., Ltd. lowest stock price was ¥356.00 and its highest was ¥603.00 in the past 12 months.
    What is Immuno-Biological Laboratories Co., Ltd.’s market cap?
    Immuno-Biological Laboratories Co., Ltd.’s market cap is ¥4.58B.
      When is Immuno-Biological Laboratories Co., Ltd.’s upcoming earnings report date?
      Immuno-Biological Laboratories Co., Ltd.’s upcoming earnings report date is Aug 08, 2025 which is in 28 days.
        How were Immuno-Biological Laboratories Co., Ltd.’s earnings last quarter?
        Immuno-Biological Laboratories Co., Ltd. released its earnings results on May 14, 2025. The company reported ¥12.42 earnings per share for the quarter, beating the consensus estimate of N/A by ¥12.42.
          Is Immuno-Biological Laboratories Co., Ltd. overvalued?
          According to Wall Street analysts Immuno-Biological Laboratories Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Immuno-Biological Laboratories Co., Ltd. pay dividends?
            Immuno-Biological Laboratories Co., Ltd. pays a Notavailable dividend of ¥5 which represents an annual dividend yield of N/A. See more information on Immuno-Biological Laboratories Co., Ltd. dividends here
              What is Immuno-Biological Laboratories Co., Ltd.’s EPS estimate?
              Immuno-Biological Laboratories Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Immuno-Biological Laboratories Co., Ltd. have?
              Immuno-Biological Laboratories Co., Ltd. has 9,314,590 shares outstanding.
                What happened to Immuno-Biological Laboratories Co., Ltd.’s price movement after its last earnings report?
                Immuno-Biological Laboratories Co., Ltd. reported an EPS of ¥12.42 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.702%.
                  Which hedge fund is a major shareholder of Immuno-Biological Laboratories Co., Ltd.?
                  Currently, no hedge funds are holding shares in JP:4570

                  Company Description

                  Immuno-Biological Laboratories Co., Ltd.

                  Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Ribomic, Inc.
                  BrightPath Biotherapeutics Co.Ltd.
                  Delta-Fly Pharma, Inc.
                  FunPep Company Limited
                  Kringle Pharma, Inc.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis